Virus-Specific T Cells are a form of advanced immunotherapy that enhances the body’s natural ability to fight viral infections. These cells are selectively expanded to target viruses like CMV, EBV, and adenovirus, offering a safer and more effective treatment option for patients with weakened immune systems, particularly after stem cell or organ transplantation. https://xelleratherapeutics.wordpress.com/2026/01/02/virus-specific-t-cells-a-targeted-approach-to-immune-therapy/